• Forum
  • Aktiemarkeder
    • MarkederRealtidskurser, indekser og markedsudvikling
    • BørskalenderKommende resultater, noteringer og virksomhedsbegivenheder
    • UdbyttekalenderKommende og tidligere udbytter
  • Selskaber
    • SelskaberGennemse og filtrer den fulde liste over børsnoterede selskaber
    • OpdagInspiration til din næste investering
    • BørsnoteringerNye noteringer og kommende børsintroduktioner
    • Invitationer til generalforsamlingerDatoer for generalforsamlinger og aktionærinformation
  • Aktieanalyse
    • ResearchEkspertaktieanalyse og anbefalinger
    • ArtiklerNyheder, indsigter og markedskommentarer
    • inderesTVVideocenter for aktieanalyse, forskning og ekspertkommentarer
    • TransskriptionerFuldstændige udskrifter af resultatopkald og investormøder
    • AktieoversigtSammenlign nøgletal og udvikling på tværs af flere aktier
Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer

Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.

Eksterne analyser

Infrea: Weak numbers but with positive signals - ABG

Infrea

Dette er en ekstern analyse og afspejler ikke nødvendigvis vores perspektiv eller værdier

Download analyse (PDF)
* Sales -15%, adj. EBITA -15% vs. ABGSCe, -15% org. growth
* '26e-'28e adj. EBITA estimates likely down 5-10%
* Share to focus on cash flow and market activity


Q1 details

Infrea delivered a slightly soft report in a small quarter. Organic sales was -15% y-o-y, and EBITA margin a bit weak driven by project mix and investments in machinery and people. In Q4'25, Infrea sold the Water & Sewage segment. We included the segment in the comparable numbers for '25. Sales came in at SEK 319m (-15% vs. ABGSCe), -15% organic (+3% Q4'25), driven by both Land & Construction and Paving services. Adj. EBITA declined SEK 6m to SEK -11m in Land & Construction (vs ABGSC at -7m, Q1'25 at -5m) while EBITA was flat in Paving Services at SEK -35m (+2% vs. ABGSCe at -36m). EBITA margin came in at -15.2% (ABGSCe -11.3%) driven by project mix and a colder winter vs. 2025.


Estimate changes and outlook


Looking ahead, management is not providing a formal outlook. However, we know the market is tough in some regions. Nevertheless, we consider Infrea's positive internal development in terms of good cash flow and comments about tenter activity to be signs that it is navigating the market well. We expect estimates for '26e-'28e adj. EBITA to come down 5-10%.


Final thoughts

A slightly soft report with in a small quarter with sales and adj. EBITA below with our expectations. The share has underperformed the broader market into numbers (L1M) and is trading at 7-5x EBITA '26e-'28e. We believe that the market will focus on the continued positive margin development resulting from Infrea's hard internal work.